Cardiac and metabolic effects of calcium and vitamin-D supplementation with conventional treatment in patients of polycystic ovarian syndrome

Cardiometabolic and hormonal profile in patients of polycystic ovarian syndrome supplemented with calcium and vitamin-D to conventional myo-inositol treatment: a randomized controlled trial. - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/03/106796

Enrollment

114

Registered

2026-03-24

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Calcium 500 mg + Vitamin D3 250 IU tablet: Calcium 500 mg + Vitamin D3 250 IU tablet administered orally once daily after meals for 12 weeks Control Intervention1: Conventional treatmen

Eligibility

Inclusion criteria

Inclusion criteria: -Patients of 18 to 45 years age group. -Newly diagnosed PCOS patients as per Rotterdam Criteria. -Patients willing to give Consent.

Exclusion criteria

Exclusion criteria: -Patient aged less than 18 years or greater than 45 years. -Participants who have received vitamin supplementation, insulin sensitizers or any other hormonal treatment within the last 3months. -Patients with known adrenal disorders. -Patients with thyroid dysfunction. -Patients with a history of long-standing Diabetes Mellitus. -Patients with severe debilitating disorders. -Patient unwilling to provide voluntary informed consent for participation. -Pregnant women and lactating mothers.

Design outcomes

Primary

Measure	Time frame
Change in cardiometabolic and hormonal parameters from baseline to 12 weeks of interventionTimepoint: Base line (Day 0) and at 12 weeks after intervention	—

Secondary

Measure	Time frame
nilTimepoint:	—

Countries

India

Contacts

Public ContactPinki Vishwakarma

LLRM Medical College, Meerut

anjaliaug9@gmail.com8755937984

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026